MedTrace Logo

RenalGuard System for Prevention of Contrast Induced Nephropathy

NCT02029820 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2014-01-08

No results posted yet for this study

Summary

The purpose of this study is to determine whether hydration with intravenous saline matched with urine output, using the device RenalGuard is superior to standard hydration with saline to prevent contrast-induced nephropathy.

Conditions

  • Radiographic Contrast Agent Nephropathy

Interventions

DEVICE

RenalGuard

Intravenous saline hydration matched with urine output, using the device Renalguard

Sponsors & Collaborators

  • Hospital Sao Lucas da PUCRS

    lead OTHER

Principal Investigators

  • Vitor O Gomes, MD,PhD · Hospital Sao Lucas

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02029820 on ClinicalTrials.gov